Pneumatic displacement and intravitreal bevacizumab: A new approach for management of submacular hemorrhage in choroidal neovascular membrane
Choroidal neovascular membrane (CNVM) is one of the most common causes of submacular hemorrhage (SMH). Conventional treatment involves management of the SMH with pneumatic displacement with or without tissue plasminogen activator (TPA) followed by intravitreal injection of bevacizumab in a second si...
Main Authors: | Chawla Shobhit, Misra Vishal, Khemchandani Mohit |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2009-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2009;volume=57;issue=2;spage=155;epage=157;aulast=Chawla |
Similar Items
-
IMPORTANCE OF CHOROIDAL THICKNESS MEASUREMENT IN PATIENTS WITH SUBMACULAR NEOVASCULAR MEMBRANE
by: A. V. Doga, et al.
Published: (2015-10-01) -
Submacular surgery
by: Saxena Sandeep, et al.
Published: (1997-01-01) -
Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
by: Ramin Nourinia, et al.
Published: (2010-01-01) -
Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
by: Sachdev Nishant, et al.
Published: (2007-01-01) -
Intravitreal Bevacizumab Injection Therapy in a Case with Choroidal Neovascular Membrane Secondary to Toxoplasmosis Retinochoroiditis
by: Sirel Gür Güngör, et al.
Published: (2014-05-01)